Model Number: | 30992-29-1 |
---|---|
Brand Name: | hanhong |
Classification: | Specific Reagents |
Purity: | 98% |
Place of Origin: | China (Mainland) |
Other Names: | Boc-Aib-OH |
CAS No.: | 30992-29-1 |
Quick Details
Specifications
Name | BOC-alpha-Methylalanine | EINECS | 250-421-0 |
CAS No. | Density | 1.104 g/cm3 | |
Solubility | Melting Point |
118-122 °C |
|
Formula | C9H17NO4 | Boiling Point | 327.625 °C at 760 mmHg |
Molecular Weight | 203.24 | Flash Point | 151.943 °C |
Transport Information | Appearance | white crystalline powder | |
Safety | 24/25 | Risk Codes | |
Molecular Structure | Hazard Symbols | ||
Synonyms |
The BOC-alpha-Methylalanine, with the CAS registry number 30992-29-1, is also known as 2-[(tert-Butoxycarbonyl)amino]-2-methylpropionic acid. It belongs to the product category of Amino Acids. Its EINECS number is 250-421-0. This chemical's molecular formula is C9H17NO4 and molecular weight is 203.24. What's more, its systematic name is 2-Methyl-N-{[(2-methyl-2-propanyl)oxy]carbonyl}alanine. When using it, you must avoid contact with skin and eyes. This chemical should be sealed and stored at the temperature of 0 - 6 °C. Moreover, it should be protected from oxides. It is used as pharmaceutical intermediate.
Physical properties of BOC-alpha-Methylalanine are: (1)ACD/LogP: 1.45; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.37; (4)ACD/LogD (pH 7.4): -1.98; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 2.24; (8)ACD/KOC (pH 7.4): 1.00; (9)#H bond acceptors: 5; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 4; (12)Polar Surface Area: 75.63 ?2; (13)Index of Refraction: 1.462; (14)Molar Refractivity: 50.61 cm3; (15)Molar Volume: 184.117 cm3; (16)Polarizability: 20.064×10-24cm3; (17)Surface Tension: 37.26 dyne/cm; (18)Density: 1.104 g/cm3; (19)Flash Point: 151.943 °C; (20)Enthalpy of Vaporization: 62.653 kJ/mol; (21)Boiling Point: 327.625 °C at 760 mmHg ; (22)Vapour Pressure: 0 mmHg at 25°C.
Preparation of BOC-alpha-Methylalanine: this chemical can be prepared by Boc-Aib-OBzl. This reaction will need reagent H2. This reaction will also need catalyst Pd/C. The yield is about 95%.
Hanhong Pharmaceutical intermediates
Core competencies: The ability to custom synthesis in pharmaceutical intermediates.
Lapatinib intermediates
Sodium methanesulfinate/20277-69-4
2-Aminoethylmethylsulfone hydrochloride/104458-24-4
Gefitinib intermediates
Methyl 3-hydroxy-4-methoxybenzoate/6702-50-7
Dasatinib intermediates
4,6-Dihydroxy-2-methylpyrimidine/40497-30-1
4,6-Dichloro-2-methylpyrimidine/1780-26-3
(S)-(+)-3-Hydroxytetrahydrofuran/86087-23-2
Enalapril maleateintermediates
L-Alanyl-L-proline/13485-59-1
L-Alanyl-L-proline Hydrochloride/88098-06-0
H-ALA-PRO-OBZL.HCL 82717-96-2
L-Alanine benzyl ester hydrochloride/5557-83-5
L-Alanine benzyl ester 4-toluenesulfonate/42854-62-6
Trandolaprilat intermediates
(S)-(-)-Indoline-2-carboxylic acid/79815-20-6
(2S,3AS,7aS)-Benzyl octahydro-1H-indole-2-carboxylate 4-methylbenzenesulfonate/94062-52-9
N-(tert-Butoxycarbonyl)-L-alanine 15761-38-3
Perindoprilat intermediates
(S)-(-)-Indoline-2-carboxylic acid/79815-20-6
Indoline-2-carboxylic acid/78348-24-0
L-Octahydroindole-2-carboxylic acid/80875-98-5
N-[(S)-1-Carbethoxy-1-butyl]-(S)-alanine/82834-12-6
Lisinopril intermediates
Z-Lys(Boc)-OH.DCHA 2212-76-2
L-Proline benzyl ester hydrochloride /16652-71-4
H-Lys(Tfa)-OH 10009-20-8
H-Lys-Pro-OH 52766-27-5
N2-(1S-Ethoxycarbonyl-3-phenylpropyl)-N6-trifluoroacetyl-L-lysine/116169-90-5
N2-(1S-Ethoxycarbonyl-3-phenylpropyl)-N6-trifluoroacetyl-L-lysine
Cilazapril intermediates
D(-)-Glutamic acid/6893-26-1
gamma-Benzyl L-glutamate/1676-73-9
Quinapril hydrochloride intermediates
L-Alanine benzyl ester hydrochloride/5557-83-5
DCC HOBT
L-Alanine benzyl ester 4-toluenesulfonate/42854-62-6
Benzyl (S)(-)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylate p-toluenesulfonic acid salt/77497-97-3
Zofenoprilat intermediates
Oxaceprol/33996-33-7
cis-4-Phenylthio-L-proline hydrochloride/105107-84-4
Atazanavir intermediates
Methoxycarbonyl-L-tert-leucine/162537-11-3
N-Boc-L-tert-Leucine/62965-35-9
L-tert-Leucine/20859-02-3
Indinavir intermediates
(1S,2R)-(-)-cis-1-Amino-2-indanol/126456-43-7
2-Aminobutanol/5856-63-3
(S)-Piperazine-2-carboxylic acid/147650-70-2
(S)-2-tert-Butylcarboxamide-4-tert-butoxycarbonyl piperazine/150323-35-6
(S)-2-tert-Butylcarboxamide-4-tert-butoxycarbonyl piperazine
3-Pyridinecarboxaldehyde/500-22-1
Daclatasvir (BMS-790052) intermediates
MOC-L-Valine/74761-42-5
Eptifibatide intermediates
Fmoc-Asp(Otbu)-OH 71989-14-5
Fmoc-Gly-OH 29022-11-5
Fmoc-Pro-OH 71989-31-6
Fmoc-Trp(Boc)-OH 143824-78-6
Mpa(Trt)-OH 27144-18-9
Fmoc-Cys(Trt)-OH 103213-32-7
Thymopentin intermediates
HOBT 2592-95-2
HBTU 94790-37-1
Fmoc-Tyr(otbu)-OH 71989-38-3
Fmoc-Val-OH 68858-20-8
Fmoc-Asp(Otbu)-OH 71989-14-5
Fmoc-Lys(Boc)-OH 71989-26-9
Fmoc-Arg(Pbf)-OH 154445-77-9
Sofosbuvir intermediates
H-ALA-OIPR HCL /39825-33-7
N4-Benzoylcytosine/26661-13-2
Ambrisentan intermediates
2-HYDROXY-3-METHOXY-3,3-DIPHENYLPROPANOIC ACID/178306-51-9
Benzenepropanoic acid,a-hydroxy-b-methoxy-b-phenyl-,methyl ester /178306-47-3
4,6-Dimethyl-2-methylsulfonylpyrimidine/35144-22-0
L-1-Phenylethylamine/2627-86-3
Methyl L-prolinate hydrochloride/2133-40-6
zolmitriptan intermediates
4-Nitro-L-phenylalanine monohydrate/207591-86-4
1,1-Dimethoxy-N,N-dimethyl-1-butanamine/19718-92-4
(S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone/152305-23-2
Eletriptan intermediates
N-Benzyloxycarbonyl-D-proline/6404-31-5
5-Bromoindole/10075-50-0
Cialis intermediates
D-Tryptophan methyl ester hydrochloride/14907-27-8
D(+)-Tryptophan/153-94-6
Ubenimex intermediates
L-Leucine benzyl ester p-toluenesulfonate salt/1738-77-8
3-AMINO-2-HYDROXY-4-PHENYLBUTYRIC ACID/59554-14-2
DIETHYL D-(-)-TARTRATE/13811-71-7
LCZ696 intermediates
L-4,4'-BIPHENYLALANINE/155760-02-4
D-4,4'-BIPHENYLALANINE/170080-13-4
BOC-L-4,4'-BIPHENYLALANINE/147923-08-8
BOC-D-4,4'-BIPHENYLALANINE/128779-47-5
(R)-tert-butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate/1426129-50-1
Trifluridine intermediates
6-(Chloromethyl)uracil/18592-13-7 ≥99%
Trifluorothymine/ 54-20-6 ≥99%
1-Chloro-3,5-di-(4-chlorobenzoyl)-2-deoxy-D-ribose/21740-23-8/3601-90-9
Bortezomib intermediates
(S)-N-Boc-3-Amino-3-phenylpropanoic acid/103365-47-5
Boc-Phe-OH 13734-34-4
CVT-510 intermediates
6-Chloropurine ribonucleoside/5399-87-1/2004-06-0
(S)-3-AMINOTETRAHYDROFURAN/104530-79-2
Glatiramer acetate intermediates
H-TYR-NCA/3415-08-5
H-GLU(OBZL)-NCA/3190-71-4
N6-Trifluoroacetyl-L-lysine N-Carboxyanhydride /42267-27-6
(S)-4-METHYL-2,5-OXAZOLIDINEDIONE/2224-52-4
Folic acid intermediates
P-NITROBENZOYL-L-GLUTAMIC ACID/6758-40-3
N-(4-Aminobenzoyl)-L-glutamic acid/ 4271-30-1
TICAGRELOR intermediates
BOC-D-Alanine/7764-95-6
D-Alanine/338-69-2
CDI 530-62-1
Argatroban intermediates
N'-Nitro-L-arginine/2149-70-4